切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Epac - Thymidylate Synthase - CSF-1R - 5-HT2 Receptor

10 件产品

每页
清除全部
  1. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: 酪氨酸激酶抑制剂(TKI)
      ≥10.62 mg/mL
      ≥168.2 mg/mL
  2. BLZ945
    B4899 BLZ945
     1 Citation
    Target: CSF-1R
    Summary: CSF-1R激酶抑制剂
      ≥19.9 mg/mL
      insoluble in H2O
  3. SCH 23390 hydrochloride
    B6506 SCH 23390 hydrochloride
    Target: dopamine receptor|5-HT1 Receptor|5-HT2 Receptor
    Summary: 多巴胺受体拮抗剂
      Soluble to 100 mM in sterile water and to 50 mM in ethanol
  4. Methylergometrine maleate
    B6347 Methylergometrine maleate
    中文名: 马来酸甲麦角新碱
    Target: 5-HT1 Receptor|5-HT2 Receptor
    Summary: 5-HT1/5-HT2受体拮抗剂
      Soluble to 25 mM in H2O
  5. 8-CPT-2Me-cAMP, sodium salt
    B6816 8-CPT-2Me-cAMP, sodium salt
    Target: Epac
    Summary: EPAC活化剂
      <50.78 mg/mL
  6. Raltitrexed
    B1476 Raltitrexed
    中文名: 雷替曲塞
    Target: Thymidylate Synthase
    Summary: 胸苷酸合酶抑制剂
      ≥154 mg/mL
      insoluble in H2O
  7. GW2580
    A1655 GW2580
     1 Citation
    Target: CSF-1R
    Summary: CFMS激酶/CSF-1R抑制剂
      ≥36.6 mg/mL
      insoluble in H2O
  8. Pemetrexed
    A4390 Pemetrexed
     1 Citation
    中文名: 培美曲塞二钠盐
    Target: Thymidylate Synthase|DHFR|GARFT
    Summary: TS、DHFR、GARFT和AICARFT抑制剂
      ≥15.68 mg/mL
      ≥30.67 mg/mL
  9. Fluorouracil (Adrucil)
    A4071 Fluorouracil (Adrucil)
     3 Citation
    中文名: 氟尿嘧啶
    Target: Thymidylate Synthase
    Summary: 胸苷酸合成酶抑制剂,抗肿瘤药物。
      ≥13.04 mg/mL
      ≥10.04 mg/mL
  10. Pazopanib (GW-786034)
    A3022 Pazopanib (GW-786034)
    中文名: 帕唑帕尼
    Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFR
    Summary: (GW-786034)VEGFR/PDGFR/FGFR 的抑制剂。
      ≥10.95 mg/mL
      insoluble in H2O

10 件产品

每页